Search hospitals > Maryland > Rosedale

Franklin Square Hospital Center

Claim this profile
Rosedale, Maryland 21237
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Heart Failure
92 reported clinical trials
4 medical researchers
Photo of Franklin Square Hospital Center in RosedalePhoto of Franklin Square Hospital Center in RosedalePhoto of Franklin Square Hospital Center in Rosedale

Summary

Franklin Square Hospital Center is a medical facility located in Rosedale, Maryland. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer, Heart Failure and other specialties. Franklin Square Hospital Center is involved with conducting 92 clinical trials across 144 conditions. There are 4 research doctors associated with this hospital, such as Edward McCarron, Dr. Gary Volkel, MD, Shawna Willey, MD, and Derrick Fox.

Area of expertise

1Breast Cancer
Global Leader
Franklin Square Hospital Center has run 19 trials for Breast Cancer. Some of their research focus areas include:
Stage III
Stage IV
Stage I
2Lung Cancer
Global Leader
Franklin Square Hospital Center has run 17 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
EGFR negative
ALK negative

Top PIs

Clinical Trials running at Franklin Square Hospital Center

Lung Cancer
Parkinson's disease
Breast Cancer
Colorectal Cancer
Stroke
Cancer
Non-Small Cell Lung Cancer
Bedsores
Hypertrophic Cardiomyopathy
Mitral Regurgitation
Image of trial facility.

Pembrolizumab + Chemotherapy

for Non-Small Cell Lung Cancer

The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) with or without chemotherapy in combination with vibostolimab (MK-7684), boserolimab (MK-5890), MK-4830, MK-0482, I-DXd, or HER3-DXd in treatment-naïve participants with advanced squamous or non-squamous NSCLC. This study is one of the pembrolizumab substudies being conducted under one pembrolizumab umbrella master protocol (MK-3475-U01/KEYMAKER-U01).
Recruiting1 award Phase 1 & 28 criteria
Image of trial facility.

Pembrolizumab + Investigational Agents

for Lung Cancer

The main goals are after treatment given before surgery, to measure the number of people who have no signs of cancer cells in tumors and lymph nodes removed during surgery; and to learn about whether the cancer gets smaller or goes away by measuring the number of people with a certain number of living cancer cells in the tumor removed during surgery.
Recruiting1 award Phase 2
Image of trial facility.

Pembrolizumab + Chemotherapy

for Lung Cancer

Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and lung cancer that has spread beyond surgical removal. Standard treatments include immunotherapy, such as pembrolizumab, and chemotherapy. This study aims to determine the effectiveness of adding other treatments, including the human epidermal growth factor receptor 3-directed antibody-drug conjugate (HER3-DXd) patritumab deruxtecan, to pembrolizumab, with or without chemotherapy. The primary goals are to assess safety and efficacy of the treatments.
Recruiting1 award Phase 23 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Franklin Square Hospital Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security